Research Article

[Retracted] A Novel Identified Peptide Hormone “Metabolitin” Attenuates Lipid Absorption in the Small Intestine of Diabetic Mice with Nonalcoholic Fatty Liver Disease by Regulating Neurotensin and AMPK Signaling Pathway

Figure 3

Oral administration of metabolitin activated the NT-AMPK signaling pathway in T2DM/NAFLD mice. (a, b) The p-AMPK/AMPK in the mouse intestinal tissues was evaluated by Western blot analysis. (c, d) The NT level in the serum and feces of the mice after Oil Red O treatment. (e) The NT level in the serum of the mice after oral administration of metabolitin. In (b) and (e), compared to the normal group; and compared to the model group. In (c) and (d), compared to the saline + saline group and compared to the saline + Oil Red O group.
(a)
(b)
(c)
(d)
(e)